Pacira BioSciences, Inc. (NASDAQ:PCRX)
Industry: Drug Manufacturers - Specialty & Generic

OFF LIST - 797 consecutive market days: OFF LIST as of 04/05/2013 Through 11/14/2016

Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature only to targeted nerves. It also develops proprietary multivesicular liposome, a drug delivery technology that encapsulates drugs without altering their molecular structure. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.

Current Quote*
Last: $23.700
Change: 0.000
Book: $3.088
Volume: 248,773

As Of: 07/10 16:13 ET
*Quotes delayed by 20min.

Graphs for PCRX


3 Month Graph


6 Month Graph


1 Year Graph